Biocept Secures Agreement with FedMed
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Biocept (BIOC) Reports Q4 Loss of $0.24
March 9, 2016 5:05 PM ESTBiocept (NASDAQ: BIOC) reported Q4 EPS of ($0.24), versus ($0.87) reported last year. Revenue for the quarter came in at $218 million, versus $76 million reported last year.
For earnings history and earnings-related data on Biocept (BIOC) click here.
... More